Procter & Gamble Co. reaped benefits in its latest quarter both from investing in grooming, where sales grew 4%, and from acquiring Merck KGaA’s OTC business, which fueled 7% growth in the first earnings period the US firm included the German pharma’s former brands in its organic growth rate.
The strong results in P&G’s fiscal year 2020 second quarter for the grooming business, also including increasing its global market share and adding 18m customers in 12 months, mark its third consecutive quarter of growth, reaching $1.65bn
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?